Medibank Private (ASX:MPL) share price dips despite 27% profit boost

The Medibank Private Limited (ASX:MPL) share price is down today, despite the release of strong half-yearly results for FY20 from the insurer.

| More on:
ASX share price movement represented by doctor pressing digitised screen with array of icons including one entitled health insurance,

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Medibank Private Ltd (ASX: MPL) shares are under pressure today following the release of the insurer's half-yearly results for FY21.

At the time of writing, the Medibank share price has dipped to $2.83, down 2.08%.

What did Medibank announce today?

The private health insurance provider announced a net profit after tax of $226.4 million for the 6 months ending 31 December 2020 – a 27.3% increase compared to the prior corresponding period (pcp).

The company attributed the increased profit primarily to a net gain of 49,000 policy holders over the period. 17,600 of these new customers signed up for Medibank-branded insurance itself.

"This is the first time we have grown the Medibank brand in any 6-month period since 2013 and this trend has continued into February," the company said in a media release today.

Medibank's results stand in stark contrast to the private health insurance industry at large. According to the Australian Prudential Regulatory Authority, industry profitability was down by 2 percentage points on the pcp — driven largely by the COVID-19 pandemic.

The pandemic led many private health insurance providers, including Medibank, to postpone premium increases for 6 months. Medibank stated the postponement cost the company $109 million in revenue. Despite this, revenue from premiums did rise 0.3% to $3.3 billion.

In further good news for shareholders, net claims expenses also decreased by 0.8% compared to the pcp, or $24.1 million. Gross claims fell by 1.8%, including a $99 million COVID-related reduction in claims and risk equalisation payable for the period. Underlying claims, adjusted for COVID impacts and provision movements, rose by 2.6%.

The company announced a dividend of 5.8 cents per share fully franked.

Medibank CEO to retire

Along with today's financial announcements, Medibank Private CEO Craig Drummond announced he is retiring from the position come 30 June.

Mr Drummond made the following comments about the results release and his impending retirement.

"Pleasingly Medibank is on a clear strategic path to grow the private health insurance business at a faster rate and continue its transformation into a broader healthcare company."

"Leading Medibank through this transition has been incredibly rewarding."

The Medibank share price during Mr Drummond's tenure saw a modest decline – starting around $3 when he first started while opening this morning at $2.89. During his time, Medibank shares hit a high of $3.65 and a low of $2.33.

Future outlook

Medibank is continuing its investment in healthcare. The company also announcing an expansion of its no gap joint replacement pilot into 6 regions. The pilot is a part of the company's investment into a 'short-stay model of care' program – a long-term venture aiming to reduce hospital-related expenses for both customer and company.

As of 15 February, Medibank Private is still the leading private health insurance company in Australia with a 26.9% market share and 3.7 million customers, according to comparison site ComparingExpert.

Motley Fool contributor Marc Sidarous has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Lab worker puts hands in the air and dances around
Share Gainers

$6,000 invested in this ASX 200 stock 5 years ago is now worth $84,000!

ASX 200 investors who bought this growth stock five years ago have achieved remarkable gains.

Read more »

Three analysts look at tech options on a wall screen
Technology Shares

Up 30% in 2024, 3 reasons why Xero shares could still be a fantastic buy

I view this business as one of the most impressive stocks on the ASX.

Read more »

A Chinese investor sits in front of his laptop looking pensive and concerned about pandemic lockdowns which may impact ASX 200 iron ore share prices
Share Market News

5 things to watch on the ASX 200 on Tuesday

It looks like a tough session awaits Aussie investors today.

Read more »

Four young friends on a road trip smile and laugh as they sit on roof of their car.
Opinions

If I were in my 20s, I'd want to buy these ASX shares

I believe these investments offer a lot of value.

Read more »

Man with backpack spreading his arms out and soaking in the sun.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a great start to the week's trading for ASX shares today.

Read more »

a gloved hand holds lumps of silver against a background of dirt as if at a mine site.
Materials Shares

These ASX silver shares are leaping more than 10% amid relentless rally

Some silver shares are doing even better than gold today.

Read more »

Concept image of a businessman riding a bull on an upwards arrow.
Share Market News

3 exciting ASX ETFs for growth investors in 2025 and beyond

Let's see why these funds could be great options for growth investors right now.

Read more »

A woman wearing a top of gold coins and large gold hoop earrings and a heavy gold bracelet stands amid a shower of gold coins with her mouth open wide and an excited look on her face.
Gold

14 ASX gold stocks unearthing fresh 52-week highs today

Do you own any of these hot gold miners?

Read more »